Crohn’s Disease Diagnostic and Therapeutic Market, Global Outlook and Forecast 2023-2028

Report ID: 1632853 | Published Date: Jan 2025 | No. of Page: 67 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Crohn’s Disease Diagnostic and Therapeutic Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Crohn’s Disease Diagnostic and Therapeutic Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Crohn’s Disease Diagnostic and Therapeutic Overall Market Size
    2.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Size: 2021 VS 2028
    2.2 Global Crohn’s Disease Diagnostic and Therapeutic Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Crohn’s Disease Diagnostic and Therapeutic Players in Global Market
    3.2 Top Global Crohn’s Disease Diagnostic and Therapeutic Companies Ranked by Revenue
    3.3 Global Crohn’s Disease Diagnostic and Therapeutic Revenue by Companies
    3.4 Top 3 and Top 5 Crohn’s Disease Diagnostic and Therapeutic Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Crohn’s Disease Diagnostic and Therapeutic Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Crohn’s Disease Diagnostic and Therapeutic Players in Global Market
        3.6.1 List of Global Tier 1 Crohn’s Disease Diagnostic and Therapeutic Companies
        3.6.2 List of Global Tier 2 and Tier 3 Crohn’s Disease Diagnostic and Therapeutic Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Crohn’s Disease Diagnostic and Therapeutic Market Size Markets, 2021 & 2028
        4.1.2 Diagnostics
        4.1.3 Treatment
    4.2 By Type - Global Crohn’s Disease Diagnostic and Therapeutic Revenue & Forecasts
        4.2.1 By Type - Global Crohn’s Disease Diagnostic and Therapeutic Revenue, 2017-2022
        4.2.2 By Type - Global Crohn’s Disease Diagnostic and Therapeutic Revenue, 2023-2028
        4.2.3 By Type - Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Crohn’s Disease Diagnostic and Therapeutic Market Size, 2021 & 2028
        5.1.2 Hospital
        5.1.3 Medical Research Institute
        5.1.4 Other
    5.2 By Application - Global Crohn’s Disease Diagnostic and Therapeutic Revenue & Forecasts
        5.2.1 By Application - Global Crohn’s Disease Diagnostic and Therapeutic Revenue, 2017-2022
        5.2.2 By Application - Global Crohn’s Disease Diagnostic and Therapeutic Revenue, 2023-2028
        5.2.3 By Application - Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Crohn’s Disease Diagnostic and Therapeutic Market Size, 2021 & 2028
    6.2 By Region - Global Crohn’s Disease Diagnostic and Therapeutic Revenue & Forecasts
        6.2.1 By Region - Global Crohn’s Disease Diagnostic and Therapeutic Revenue, 2017-2022
        6.2.2 By Region - Global Crohn’s Disease Diagnostic and Therapeutic Revenue, 2023-2028
        6.2.3 By Region - Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Crohn’s Disease Diagnostic and Therapeutic Revenue, 2017-2028
        6.3.2 US Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
        6.3.3 Canada Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
        6.3.4 Mexico Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Crohn’s Disease Diagnostic and Therapeutic Revenue, 2017-2028
        6.4.2 Germany Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
        6.4.3 France Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
        6.4.4 U.K. Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
        6.4.5 Italy Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
        6.4.6 Russia Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
        6.4.7 Nordic Countries Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
        6.4.8 Benelux Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Crohn’s Disease Diagnostic and Therapeutic Revenue, 2017-2028
        6.5.2 China Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
        6.5.3 Japan Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
        6.5.4 South Korea Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
        6.5.5 Southeast Asia Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
        6.5.6 India Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Crohn’s Disease Diagnostic and Therapeutic Revenue, 2017-2028
        6.6.2 Brazil Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
        6.6.3 Argentina Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Revenue, 2017-2028
        6.7.2 Turkey Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
        6.7.3 Israel Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
        6.7.4 Saudi Arabia Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
        6.7.5 UAE Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
7 Players Profiles
    7.1 Abbvie
        7.1.1 Abbvie Corporate Summary
        7.1.2 Abbvie Business Overview
        7.1.3 Abbvie Crohn’s Disease Diagnostic and Therapeutic Major Product Offerings
        7.1.4 Abbvie Crohn’s Disease Diagnostic and Therapeutic Revenue in Global Market (2017-2022)
        7.1.5 Abbvie Key News
    7.2 Celgene
        7.2.1 Celgene Corporate Summary
        7.2.2 Celgene Business Overview
        7.2.3 Celgene Crohn’s Disease Diagnostic and Therapeutic Major Product Offerings
        7.2.4 Celgene Crohn’s Disease Diagnostic and Therapeutic Revenue in Global Market (2017-2022)
        7.2.5 Celgene Key News
    7.3 Genetech
        7.3.1 Genetech Corporate Summary
        7.3.2 Genetech Business Overview
        7.3.3 Genetech Crohn’s Disease Diagnostic and Therapeutic Major Product Offerings
        7.3.4 Genetech Crohn’s Disease Diagnostic and Therapeutic Revenue in Global Market (2017-2022)
        7.3.5 Genetech Key News
    7.4 Johnson & Johnson
        7.4.1 Johnson & Johnson Corporate Summary
        7.4.2 Johnson & Johnson Business Overview
        7.4.3 Johnson & Johnson Crohn’s Disease Diagnostic and Therapeutic Major Product Offerings
        7.4.4 Johnson & Johnson Crohn’s Disease Diagnostic and Therapeutic Revenue in Global Market (2017-2022)
        7.4.5 Johnson & Johnson Key News
    7.5 Pfizer
        7.5.1 Pfizer Corporate Summary
        7.5.2 Pfizer Business Overview
        7.5.3 Pfizer Crohn’s Disease Diagnostic and Therapeutic Major Product Offerings
        7.5.4 Pfizer Crohn’s Disease Diagnostic and Therapeutic Revenue in Global Market (2017-2022)
        7.5.5 Pfizer Key News
    7.6 Prometheus Laboratories
        7.6.1 Prometheus Laboratories Corporate Summary
        7.6.2 Prometheus Laboratories Business Overview
        7.6.3 Prometheus Laboratories Crohn’s Disease Diagnostic and Therapeutic Major Product Offerings
        7.6.4 Prometheus Laboratories Crohn’s Disease Diagnostic and Therapeutic Revenue in Global Market (2017-2022)
        7.6.5 Prometheus Laboratories Key News
    7.7 Salix Pharmaceuticals
        7.7.1 Salix Pharmaceuticals Corporate Summary
        7.7.2 Salix Pharmaceuticals Business Overview
        7.7.3 Salix Pharmaceuticals Crohn’s Disease Diagnostic and Therapeutic Major Product Offerings
        7.7.4 Salix Pharmaceuticals Crohn’s Disease Diagnostic and Therapeutic Revenue in Global Market (2017-2022)
        7.7.5 Salix Pharmaceuticals Key News
    7.8 Takeda Pharmaceutical
        7.8.1 Takeda Pharmaceutical Corporate Summary
        7.8.2 Takeda Pharmaceutical Business Overview
        7.8.3 Takeda Pharmaceutical Crohn’s Disease Diagnostic and Therapeutic Major Product Offerings
        7.8.4 Takeda Pharmaceutical Crohn’s Disease Diagnostic and Therapeutic Revenue in Global Market (2017-2022)
        7.8.5 Takeda Pharmaceutical Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Crohn’s Disease Diagnostic and Therapeutic Market Opportunities & Trends in Global Market
    Table 2. Crohn’s Disease Diagnostic and Therapeutic Market Drivers in Global Market
    Table 3. Crohn’s Disease Diagnostic and Therapeutic Market Restraints in Global Market
    Table 4. Key Players of Crohn’s Disease Diagnostic and Therapeutic in Global Market
    Table 5. Top Crohn’s Disease Diagnostic and Therapeutic Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Crohn’s Disease Diagnostic and Therapeutic Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Crohn’s Disease Diagnostic and Therapeutic Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Crohn’s Disease Diagnostic and Therapeutic Product Type
    Table 9. List of Global Tier 1 Crohn’s Disease Diagnostic and Therapeutic Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Crohn’s Disease Diagnostic and Therapeutic Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Crohn’s Disease Diagnostic and Therapeutic Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Crohn’s Disease Diagnostic and Therapeutic Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Crohn’s Disease Diagnostic and Therapeutic Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Crohn’s Disease Diagnostic and Therapeutic Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Crohn’s Disease Diagnostic and Therapeutic Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Crohn’s Disease Diagnostic and Therapeutic Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2023-2028
    Table 30. Abbvie Corporate Summary
    Table 31. Abbvie Crohn’s Disease Diagnostic and Therapeutic Product Offerings
    Table 32. Abbvie Crohn’s Disease Diagnostic and Therapeutic Revenue (US$, Mn), (2017-2022)
    Table 33. Celgene Corporate Summary
    Table 34. Celgene Crohn’s Disease Diagnostic and Therapeutic Product Offerings
    Table 35. Celgene Crohn’s Disease Diagnostic and Therapeutic Revenue (US$, Mn), (2017-2022)
    Table 36. Genetech Corporate Summary
    Table 37. Genetech Crohn’s Disease Diagnostic and Therapeutic Product Offerings
    Table 38. Genetech Crohn’s Disease Diagnostic and Therapeutic Revenue (US$, Mn), (2017-2022)
    Table 39. Johnson & Johnson Corporate Summary
    Table 40. Johnson & Johnson Crohn’s Disease Diagnostic and Therapeutic Product Offerings
    Table 41. Johnson & Johnson Crohn’s Disease Diagnostic and Therapeutic Revenue (US$, Mn), (2017-2022)
    Table 42. Pfizer Corporate Summary
    Table 43. Pfizer Crohn’s Disease Diagnostic and Therapeutic Product Offerings
    Table 44. Pfizer Crohn’s Disease Diagnostic and Therapeutic Revenue (US$, Mn), (2017-2022)
    Table 45. Prometheus Laboratories Corporate Summary
    Table 46. Prometheus Laboratories Crohn’s Disease Diagnostic and Therapeutic Product Offerings
    Table 47. Prometheus Laboratories Crohn’s Disease Diagnostic and Therapeutic Revenue (US$, Mn), (2017-2022)
    Table 48. Salix Pharmaceuticals Corporate Summary
    Table 49. Salix Pharmaceuticals Crohn’s Disease Diagnostic and Therapeutic Product Offerings
    Table 50. Salix Pharmaceuticals Crohn’s Disease Diagnostic and Therapeutic Revenue (US$, Mn), (2017-2022)
    Table 51. Takeda Pharmaceutical Corporate Summary
    Table 52. Takeda Pharmaceutical Crohn’s Disease Diagnostic and Therapeutic Product Offerings
    Table 53. Takeda Pharmaceutical Crohn’s Disease Diagnostic and Therapeutic Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Crohn’s Disease Diagnostic and Therapeutic Segment by Type in 2021
    Figure 2. Crohn’s Disease Diagnostic and Therapeutic Segment by Application in 2021
    Figure 3. Global Crohn’s Disease Diagnostic and Therapeutic Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Crohn’s Disease Diagnostic and Therapeutic Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Crohn’s Disease Diagnostic and Therapeutic Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Crohn’s Disease Diagnostic and Therapeutic Revenue in 2021
    Figure 8. By Type - Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share, 2017-2028
    Figure 12. US Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share, 2017-2028
    Figure 16. Germany Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 17. France Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share, 2017-2028
    Figure 24. China Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 28. India Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share, 2017-2028
    Figure 30. Brazil Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share, 2017-2028
    Figure 33. Turkey Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 37. Abbvie Crohn’s Disease Diagnostic and Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Celgene Crohn’s Disease Diagnostic and Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Genetech Crohn’s Disease Diagnostic and Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Johnson & Johnson Crohn’s Disease Diagnostic and Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Pfizer Crohn’s Disease Diagnostic and Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Prometheus Laboratories Crohn’s Disease Diagnostic and Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Salix Pharmaceuticals Crohn’s Disease Diagnostic and Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Takeda Pharmaceutical Crohn’s Disease Diagnostic and Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
67
Frequently Asked Questions
Crohn’s Disease Diagnostic and Therapeutic Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Crohn’s Disease Diagnostic and Therapeutic Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Crohn’s Disease Diagnostic and Therapeutic Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports